[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100442434":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":48,"centralContacts":53,"locations":58,"responsibleParty":75,"collaborators":35,"id":77,"slug":78,"hasResults":79,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":83,"eligibilityCriteria":84,"healthyVolunteers":85,"sex":86,"minAge":87,"maxAge":35,"enrollmentInfo":88,"targetDuration":35,"studyType":91,"phases":92,"briefSummary":94,"conditions":95,"keywords":101,"overallStatus":112,"whyStopped":35,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":117,"completionDateStruct":119,"leadSponsor":121,"locationsCount":122},{"fullName":5,"class":6},"H. Lee Moffitt Cancer Center and Research Institute","OTHER",[8,15,20,25],{"label":9,"type":10,"description":11,"interventionNames":12},"Heparin and microsieve","EXPERIMENTAL","The needle will be prepped with 500 U heparin USP per 10 mL to coat the inside of the needle. The provider will expel the tissue onto the microsieve",[13,14],"Other: wet heparinzed suction","Other: Microsieve",{"label":16,"type":10,"description":17,"interventionNames":18},"Heparin and no microsieve","The needle will be prepped with 500 U heparin USP per 10 mL to coat the inside of the needle. The provider will expel the tissue into formalin",[13,19],"Other: No microsieve",{"label":21,"type":10,"description":22,"interventionNames":23},"No heparin and microsieve","The needle not be prepped. The provider will expel the tissue onto the microsieve",[14,24],"Other: No heparin flush",{"label":26,"type":27,"description":28,"interventionNames":29},"No heparina nd no microsieve","ACTIVE_COMPARATOR","The needle not be prepped. The provider will expel the tissue into formalin",[24,19],[31,36,40,44],{"type":6,"name":32,"description":33,"armGroupLabels":34,"otherNames":35},"wet heparinzed suction","Needle flushed with 5000 Units in 10mL of heparin",[9,16],null,{"type":6,"name":37,"description":38,"armGroupLabels":39,"otherNames":35},"Microsieve","A microsieve used for tissue preparation",[9,21],{"type":6,"name":41,"description":42,"armGroupLabels":43,"otherNames":35},"No heparin flush","The needle not prepped",[21,26],{"type":6,"name":45,"description":46,"armGroupLabels":47,"otherNames":35},"No microsieve","The tissue is placed into formalin",[16,26],[49],{"name":50,"affiliation":51,"role":52},"Shaffer Mok, MD","Moffitt Cancer Center","PRINCIPAL_INVESTIGATOR",[54],{"name":50,"role":55,"phone":56,"phoneExt":35,"email":57},"CONTACT","6099804564","mok.shaffer@gmail.com",[59],{"facility":51,"status":35,"city":60,"state":61,"zip":62,"country":63,"countryCode":64,"cosmosGeoPoint":65,"geoPoint":70,"contacts":71},"Tampa","Florida","33612","United States","US",{"type":66,"coordinates":67},"Point",[68,69],-82.45843,27.94752,{"lat":69,"lon":68},[72],{"name":50,"role":55,"phone":73,"phoneExt":35,"email":74},"813-745-4673","Shaffer.Mok@moffitt.org",{"type":76,"investigatorFullName":35,"investigatorTitle":35,"investigatorAffiliation":35,"oldNameTitle":35,"oldOrganization":35},"SPONSOR","100442434","wet-heparinized-suction-for-abdominal-cancer-100442434",false,"NCT05041335","Wet Heparinized Suction for Abdominal Cancer","Wet Heparinized Suction: A Novel Technique to Enhance Tissue Acquisition for Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB) of Solid Abdominal Masses: A Randomized Prospective Trial","EUS Heparin","Inclusion Criteria:\n\n* Age ≥ 18 year\n* Non-pregnant Patients\n* Patients with the presence of a solid abdominal mass as seen on diagnostic imaging \\[ie. ultrasound (US), computer tomography (CT) or magnetic resonance imaging (MRI)\\] scheduled to undergo EUS examination OR Patients who underwent a prior EUS-FNA\u002FFNB for solid pancreatic mass and did not receive a conclusive diagnosis\n* Patients with platelet count \\> 50,000\n* Patients with International Normalized Ratio (INR) \\\u003C 1.5\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years\n* Pregnant Patients\n* Patients who cannot consent for themselves\n* Patients with anticoagulants or anti-platelet agents (excluding aspirin) within the last 7-10 days\n* Patients with cystic abdominal masses\n* Patients with a platelet count \\\u003C 50,000\n* Patients with an INR \\> 1.5\n* Patients with a heparin or porcine allergy\n* Patients with prior heparin induced thrombocytopenia (HIT)\n* Patient's with religious aversion to porcine-containing products",true,"ALL","18 Years",{"count":89,"type":90},42,"ESTIMATED","INTERVENTIONAL",[93],"NA","The purpose of this research is to compare the amount and quality of tissue obtained by EUS-FNB when the device is flushed with an anticoagulant or \"blood thinner\" vs. saline a salt water solution as well as the use of a microsieve in order for the doctor to look at the tissue to check the acceptability of the specimens before sending for analysis.\n\nYou will be randomly assigned (like a flip of a coin) to have either the blood thinner or the salt water solution placed within the needle being used to sample your abdominal tumor and to have either a sieve used or not.\n\nYou will be one of 42 participants enrolled in this data collection study which includes 1 sites in the United States.",[96,97,98,99,100],"Cancer of Pancreas","Cancer of Stomach","Cancer of Esophagus","Cancer of Liver","Cancer",[102,103,104,105,106,107,108,109,110,111],"cancer","esophagus","stomach","gastric","pancreas","biliary","bile","bile duct","liver","hepatic","NOT_YET_RECRUITING","2025-04-21",{"date":115,"type":116},"2025-04-22","ACTUAL",{"date":118,"type":90},"2026-03-15",{"date":120,"type":90},"2027-01-12",{"name":5,"class":6},1]